Extended Data Fig. 10: Flow gating strategy of anti-tumor functions of CAR-NK cells and graphical summary.
From: OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumours
a, Gating strategy of Flow cytometry of NK population and CAR expression in Fig. 2b and Extended Data Fig. 7. b, Gating strategy of Flow cytometry of degranulation in Fig. 2e. c, Gating strategy of Flow cytometry of production of effector cytokines in Fig. 2f and Fig. 2h,i. d, Gating strategy of Flow cytometry of surface FasL and TRAIL in Fig. 2g. e-g, Gating strategy of Flow cytometry of NK presentation in the Spleen, Blood, and Tumor samples in Fig. 5l–n and Extended Data Fig. 7. h, Graphical summary of OR7A10 engineering boosts CAR-NK anti-tumor functions. The schematic in h was created using BioRender (https://biorender.com).
